Status:
COMPLETED
A Study of Mircera in Renal Anemia Among Filipino Chronic Kidney Disease Patients
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Anemia
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This study will assess the efficacy and safety of once monthly administration of Mircera in Filipino patients with chronic kidney disease who are either on dialysis or predialysis, and not receiving e...
Eligibility Criteria
Inclusion
- adult patients, \>=18 years of age;
- chronic kidney disease;
- anemia (Hb \>8 and \<11 g/dL);
- regular dialysis or predialysis, not treated with ESA.
Exclusion
- transfusion of red blood cells during previous 8 weeks;
- poorly controlled hypertension;
- overt gastrointestinal bleeding, or other bleeding necessitating transfusion during previous 8 weeks;
- active malignant disease (except melanoma of skin).
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT00922610
Start Date
February 1 2009
End Date
July 1 2010
Last Update
November 2 2016
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Cavite, Philippines, 4103
2
Makati City, Philippines, 1229
3
Manila, Philippines, 1000
4
Marikina City, Philippines, 1805